Thrombotic Risk Screen Test sale cost 2890 AED
Alpha Thalassemia HBA1 – HBA2 Deletion-Duplication Analysis Test sale cost 2600 AED Alpha Thalassemia HBA1 – HBA2 Deletion-Duplication Analysis Test Cost 3,600 د.إ Original price was: 3,600 د.إ.2,600 د.إCurrent price is: 2,600 د.إ.
Vitamin K Test sale cost 2830 AED Vitamin K Test Cost 3,150 د.إ Original price was: 3,150 د.إ.2,830 د.إCurrent price is: 2,830 د.إ.
Sale!

Thrombotic Risk Screen Test Cost

Original price was: 3,400 د.إ.Current price is: 2,890 د.إ.

-15%

The Thrombotic Risk Screen Test, offered at DNA Labs UAE for a cost of 2890 AED, is a comprehensive diagnostic tool designed to assess an individual’s risk of developing thrombosis. Thrombosis refers to the formation of blood clots within blood vessels, which can lead to serious health complications such as stroke, heart attack, or deep vein thrombosis (DVT). This test analyzes genetic markers, blood clotting factors, and other relevant biomarkers to evaluate a person’s predisposition to thrombotic conditions. By identifying individuals at higher risk, the Thrombotic Risk Screen Test enables proactive measures to be taken, such as lifestyle adjustments or medical interventions, to reduce the likelihood of thrombotic events. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a crucial step for those concerned about their thrombotic risk profile, offering peace of mind and the opportunity for preventive care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

THROMBOTIC RISK SCREEN Test

Test Name: THROMBOTIC RISK SCREEN Test

Components:

  • Protein C Functional
  • Protein S antigen, Free
  • Antithrombin Activity Functional
  • APCR

Price: 2890.0 AED

Sample Condition:

  • 6mL whole blood in 2 Blue Top (Sodium Citrate) tubes.
  • Mix thoroughly by inversion.
  • Transport to Lab within 4 hours.
  • If this is not possible, make PPP within 1 hour of collection as follows:
  • Centrifuge sample at 3600rpm for 15 min. & transfer supernatant to a clean plastic tube.
  • Centrifuge this supernatant again at 3600 rpm for 15 min. & finally transfer the supernatant (PPP) to 1 labelled clean plastic screw-capped vial.
  • FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW.
  • Overnight fasting is preferred.

Report Delivery: 1 week

Method: Chromogenic, Immunoturbidimetry, Electromechanical Clot Detection

Test Type: Disorders of Coagulation

Doctor: Hematologist

Test Department: COAGULATION

Pre Test Information:

  • Overnight fasting is preferred.
  • Duly filled Coagulation Requisition Form (Form 15) is mandatory.
  • It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results.
  • Discontinuation should be with prior consent from the treating Physician.

Test Details:

The THROMBOTIC RISK SCREEN test is a diagnostic tool used to assess a person’s risk of developing blood clots, also known as thrombosis. This test is typically ordered for individuals who have a family history of blood clots or have experienced a previous clotting event.

The THROMBOTIC RISK SCREEN test evaluates various genetic and molecular markers that can indicate an increased risk of thrombosis. These markers include mutations in genes such as Factor V Leiden, prothrombin gene mutation, and methylenetetrahydrofolate reductase (MTHFR) gene mutation. Additionally, the test may also measure levels of certain proteins involved in blood clotting, such as antithrombin III, protein C, and protein S.

The results of the THROMBOTIC RISK SCREEN test can help healthcare providers determine the appropriate management and treatment strategies for individuals at risk of thrombosis. This may include lifestyle modifications, medication therapy, or preventative measures such as the use of blood thinners.

It is important to note that the THROMBOTIC RISK SCREEN test is not a definitive diagnostic tool for thrombosis. It is used as a screening tool to identify individuals who may be at an increased risk and may require further testing or intervention. A healthcare provider will interpret the test results in the context of an individual’s overall medical history and symptoms.

Test Name THROMBOTIC RISK SCREEN Test
Components *Protein C Functional* Protein S antigen, Free*AntithrombinActivityFunctional*APCR
Price 2890.0 AED
Sample Condition 6mLwholebloodin2BlueTop (SodiumCitrate)tubes.Mixthoroughly byinversion.TransporttoLabwithin4 hours.Ifthisisnotpossible,makePPP within1hourofcollectionasfollows: Centrifugesampleat3600rpmfor15 min.&transfersupernatanttoaclean plastictube.Centrifugethissupernatant again at 3600 rpm for 15 min. & finally transferthesupernatant(PPP)to1 labelled cleanplasticscrewcappedvial. FREEZE IMMEDIATELY. Ship frozen. DONOTTHAW.Overnightfastingis preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory. Itisrecommendedthatpatient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior tosamplingasthesedrugsmayaffect testresults.Discontinuationshouldbe with prior consent from the treating Physician.
Report Delivery 1 week
Method Chromogenic, Immunoturbidimetry, Electromechanical Clot Detection
Test type Disorders of Coagulation
Doctor Hematologist
Test Department: COAGULATION
Pre Test Information Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to samplingas these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.
Test Details

The THROMBOTIC RISK SCREEN test is a diagnostic tool used to assess a person’s risk of developing blood clots, also known as thrombosis. This test is typically ordered for individuals who have a family history of blood clots or have experienced a previous clotting event.

The THROMBOTIC RISK SCREEN test evaluates various genetic and molecular markers that can indicate an increased risk of thrombosis. These markers include mutations in genes such as Factor V Leiden, prothrombin gene mutation, and methylenetetrahydrofolate reductase (MTHFR) gene mutation. Additionally, the test may also measure levels of certain proteins involved in blood clotting, such as antithrombin III, protein C, and protein S.

The results of the THROMBOTIC RISK SCREEN test can help healthcare providers determine the appropriate management and treatment strategies for individuals at risk of thrombosis. This may include lifestyle modifications, medication therapy, or preventative measures such as the use of blood thinners.

It is important to note that the THROMBOTIC RISK SCREEN test is not a definitive diagnostic tool for thrombosis. It is used as a screening tool to identify individuals who may be at an increased risk and may require further testing or intervention. A healthcare provider will interpret the test results in the context of an individual’s overall medical history and symptoms.

SKU: TEST-4780 Category:

Related products